Cherokee Pharmaceuticals

Cherokee Pharmaceuticals is a premier, US-based contract manufacturing, chemical distribution and laboratory services company headquartered in Philadelphia, PA. The main production facility is located on a 323 acre site in Riverside, PA. The facility, formerly owned and operated by Merck and Company until January 2008, is an API development and production site. The site with 127 acres of development, production and storage facilities developed inside the fence-line. There is also a large fermentation facility which until 2005, produced xanthan gum. Under Cherokee, this facility has manufactured various fermented products for external biopharmaceutical and related companies. The company maintains a solid business relationship with its partner Merck; during the past year, Cherokee is expanding its core business offering contract development and manufacturing services to emerging and legacy pharmaceutical companies.Cherokee has a stellar track record with the FDA, receiving only two minor observations from CDER during multiple inspections in the past nine years.Cherokee Pharmaceuticals is a wholly owned subsidiary of PRWT Services, Inc. and is a minority owned enterprise; the company has pioneered the concept of self managed work teams which enhances flexibility and allows for rapid customer response to customer requests. The company has an excellent environmental track record. Cherokee has a leading process development and implementation team that regularly handles complex, multi-step chemical processes, scaling them from a concept to commercial quantities rapidly and efficiently.Cherokee is in the unique position that it's a startup with an almost sixty year history of production and compliance. The company is optimized to handle complex and challenging chemistries. Cherokee is the ideal partner for any pharmaceutical company that seeks competence and commitment in bringing a drug from the concept stage to commercial quantities.